Equatorial Guinea

Equatorial Guinea

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.26 (1.09 - 1.43) 2019 Modelled IHME
1.28 (1.12 - 1.44) 2018 Modelled IHME
1.3 (1.14 - 1.47) 2017 Modelled IHME
1.34 (1.17 - 1.51) 2016 Modelled IHME
1.37 (1.19 - 1.56) 2015 Modelled IHME
1.39 (1.21 - 1.59) 2014 Modelled IHME
1.4 (1.22 - 1.61) 2013 Modelled IHME
1.41 (1.22 - 1.62) 2012 Modelled IHME
1.43 (1.23 - 1.64) 2011 Modelled IHME
1.44 (1.23 - 1.67) 2010 Modelled IHME
1.46 (1.24 - 1.68) 2009 Modelled IHME
1.47 (1.26 - 1.71) 2008 Modelled IHME
1.5 (1.28 - 1.72) 2007 Modelled IHME
1.52 (1.31 - 1.75) 2006 Modelled IHME
1.55 (1.32 - 1.79) 2005 Modelled IHME
1.58 (1.36 - 1.83) 2004 Modelled IHME
1.63 (1.40 - 1.88) 2003 Modelled IHME
1.68 (1.45 - 1.95) 2002 Modelled IHME
1.73 (1.49 - 2.02) 2001 Modelled IHME
1.79 (1.52 - 2.10) 2000 Modelled IHME
1.84 (1.57 - 2.16) 1999 Modelled IHME
1.9 (1.62 - 2.22) 1998 Modelled IHME
1.96 (1.67 - 2.30) 1997 Modelled IHME
2.01 (1.70 - 2.35) 1996 Modelled IHME
2.06 (1.74 - 2.40) 1995 Modelled IHME
2.09 (1.77 - 2.44) 1994 Modelled IHME
2.13 (1.80 - 2.47) 1993 Modelled IHME
2.16 (1.83 - 2.50) 1992 Modelled IHME
2.18 (1.85 - 2.53) 1991 Modelled IHME
2.2 (1.86 - 2.56) 1990 Modelled IHME
9.34 (7.48 - 11.40) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.48 (0.36 - 0.62) 2019 Modelled IHME
0.49 (0.37 - 0.63) 2018 Modelled IHME
0.5 (0.38 - 0.64) 2017 Modelled IHME
0.66 (0.51 - 0.83) 2016 Modelled IHME
0.83 (0.63 - 1.06) 2015 Modelled IHME
0.87 (0.66 - 1.11) 2014 Modelled IHME
0.9 (0.68 - 1.14) 2013 Modelled IHME
0.91 (0.69 - 1.17) 2012 Modelled IHME
0.93 (0.70 - 1.19) 2011 Modelled IHME
0.95 (0.71 - 1.23) 2010 Modelled IHME
0.97 (0.73 - 1.26) 2009 Modelled IHME
0.99 (0.75 - 1.28) 2008 Modelled IHME
1.02 (0.77 - 1.31) 2007 Modelled IHME
1.04 (0.78 - 1.34) 2006 Modelled IHME
1.07 (0.81 - 1.38) 2005 Modelled IHME
1.11 (0.85 - 1.42) 2004 Modelled IHME
1.16 (0.89 - 1.48) 2003 Modelled IHME
1.21 (0.93 - 1.55) 2002 Modelled IHME
1.27 (0.98 - 1.62) 2001 Modelled IHME
1.33 (1.01 - 1.70) 2000 Modelled IHME
1.38 (1.06 - 1.76) 1999 Modelled IHME
1.43 (1.10 - 1.84) 1998 Modelled IHME
1.49 (1.14 - 1.91) 1997 Modelled IHME
1.54 (1.17 - 1.97) 1996 Modelled IHME
1.58 (1.20 - 2.03) 1995 Modelled IHME
1.62 (1.23 - 2.05) 1994 Modelled IHME
1.65 (1.26 - 2.08) 1993 Modelled IHME
1.68 (1.29 - 2.11) 1992 Modelled IHME
1.71 (1.31 - 2.13) 1991 Modelled IHME
1.73 (1.32 - 2.16) 1990 Modelled IHME
8.66 (6.75 - 11.20) 2015 Modelled WHO
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.29 (1.97 - 5.22) 2019 Modelled IHME
3.27 (1.98 - 5.07) 2018 Modelled IHME
3.22 (1.93 - 5.10) 2017 Modelled IHME
3.18 (1.93 - 5.01) 2016 Modelled IHME
3.12 (1.87 - 4.94) 2015 Modelled IHME
3.15 (1.91 - 4.93) 2014 Modelled IHME
3.21 (1.96 - 5.03) 2013 Modelled IHME
3.3 (2.02 - 5.17) 2012 Modelled IHME
3.36 (2.05 - 5.17) 2011 Modelled IHME
3.33 (2.03 - 5.09) 2010 Modelled IHME
3.4 (2.06 - 5.18) 2009 Modelled IHME
3.46 (2.09 - 5.27) 2008 Modelled IHME
3.6 (2.17 - 5.46) 2007 Modelled IHME
3.74 (2.25 - 5.63) 2006 Modelled IHME
3.84 (2.31 - 5.66) 2005 Modelled IHME
3.97 (2.43 - 5.81) 2004 Modelled IHME
4.13 (2.55 - 6.03) 2003 Modelled IHME
4.34 (2.69 - 6.28) 2002 Modelled IHME
4.74 (2.98 - 6.79) 2001 Modelled IHME
5.14 (3.25 - 7.36) 2000 Modelled IHME
5.48 (3.50 - 7.83) 1999 Modelled IHME
5.81 (3.72 - 8.34) 1998 Modelled IHME
6.23 (4.01 - 9.03) 1997 Modelled IHME
6.81 (4.36 - 10) 1996 Modelled IHME
7.11 (4.51 - 10.60) 1995 Modelled IHME
7.37 (4.66 - 11) 1994 Modelled IHME
7.75 (4.92 - 11.70) 1993 Modelled IHME
8.1 (5.08 - 12.20) 1992 Modelled IHME
8.5 (5.29 - 12.90) 1991 Modelled IHME
8.81 (5.56 - 13.60) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
47 (28 - 74) 2019 Modelled IHME
45 (27 - 70) 2018 Modelled IHME
43 (26 - 68) 2017 Modelled IHME
41 (25 - 65) 2016 Modelled IHME
39 (24 - 62) 2015 Modelled IHME
38 (23 - 60) 2014 Modelled IHME
38 (23 - 59) 2013 Modelled IHME
37 (23 - 58) 2012 Modelled IHME
36 (22 - 56) 2011 Modelled IHME
35 (21 - 53) 2010 Modelled IHME
34 (21 - 52) 2009 Modelled IHME
33 (20 - 51) 2008 Modelled IHME
33 (20 - 50) 2007 Modelled IHME
33 (20 - 50) 2006 Modelled IHME
32 (19 - 48) 2005 Modelled IHME
32 (20 - 47) 2004 Modelled IHME
32 (20 - 46) 2003 Modelled IHME
32 (20 - 46) 2002 Modelled IHME
33 (21 - 48) 2001 Modelled IHME
34 (22 - 49) 2000 Modelled IHME
35 (22 - 50) 1999 Modelled IHME
35 (23 - 51) 1998 Modelled IHME
36 (23 - 53) 1997 Modelled IHME
38 (24 - 56) 1996 Modelled IHME
38 (24 - 56) 1995 Modelled IHME
38 (24 - 56) 1994 Modelled IHME
38 (24 - 57) 1993 Modelled IHME
38 (24 - 57) 1992 Modelled IHME
38 (24 - 58) 1991 Modelled IHME
38 (24 - 58) 1990 Modelled IHME
165 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
27 (21 - 35) 2019 Modelled IHME
27 (21 - 34) 2018 Modelled IHME
27 (21 - 34) 2017 Modelled IHME
27 (20 - 34) 2016 Modelled IHME
27 (20 - 34) 2015 Modelled IHME
27 (20 - 34) 2014 Modelled IHME
27 (20 - 34) 2013 Modelled IHME
27 (20 - 34) 2012 Modelled IHME
27 (20 - 34) 2011 Modelled IHME
27 (20 - 34) 2010 Modelled IHME
26 (20 - 34) 2009 Modelled IHME
26 (20 - 34) 2008 Modelled IHME
26 (20 - 34) 2007 Modelled IHME
26 (20 - 34) 2006 Modelled IHME
26 (20 - 34) 2005 Modelled IHME
26 (20 - 34) 2004 Modelled IHME
26 (20 - 34) 2003 Modelled IHME
26 (20 - 34) 2002 Modelled IHME
26 (20 - 34) 2001 Modelled IHME
26 (20 - 34) 2000 Modelled IHME
26 (20 - 34) 1999 Modelled IHME
26 (20 - 35) 1998 Modelled IHME
27 (20 - 35) 1997 Modelled IHME
27 (20 - 35) 1996 Modelled IHME
27 (20 - 35) 1995 Modelled IHME
27 (20 - 35) 1994 Modelled IHME
27 (20 - 35) 1993 Modelled IHME
27 (20 - 35) 1992 Modelled IHME
27 (20 - 35) 1991 Modelled IHME
26 (20 - 35) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
25 2018 Survey/reported WHO/UNICEF
25 2017 Survey/reported WHO/UNICEF
19 2016 Survey/reported WHO/UNICEF
16 2015 Survey/reported WHO/UNICEF
20 2014 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2018
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.27 (1.82 - 2.87) 2019 Modelled IHME
2.27 (1.82 - 2.85) 2018 Modelled IHME
2.27 (1.80 - 2.86) 2017 Modelled IHME
2.26 (1.82 - 2.85) 2016 Modelled IHME
2.26 (1.81 - 2.83) 2015 Modelled IHME
2.27 (1.82 - 2.84) 2014 Modelled IHME
2.3 (1.86 - 2.88) 2013 Modelled IHME
2.34 (1.89 - 2.93) 2012 Modelled IHME
2.38 (1.93 - 2.99) 2011 Modelled IHME
2.43 (1.95 - 3.05) 2010 Modelled IHME
2.47 (2 - 3.11) 2009 Modelled IHME
2.53 (2.04 - 3.18) 2008 Modelled IHME
2.59 (2.08 - 3.24) 2007 Modelled IHME
2.66 (2.14 - 3.34) 2006 Modelled IHME
2.73 (2.19 - 3.42) 2005 Modelled IHME
2.81 (2.26 - 3.51) 2004 Modelled IHME
2.9 (2.33 - 3.63) 2003 Modelled IHME
3 (2.42 - 3.77) 2002 Modelled IHME
3.1 (2.50 - 3.89) 2001 Modelled IHME
3.21 (2.58 - 4.03) 2000 Modelled IHME
3.31 (2.66 - 4.15) 1999 Modelled IHME
3.42 (2.75 - 4.29) 1998 Modelled IHME
3.54 (2.84 - 4.47) 1997 Modelled IHME
3.65 (2.92 - 4.57) 1996 Modelled IHME
3.75 (2.99 - 4.70) 1995 Modelled IHME
3.84 (3.08 - 4.82) 1994 Modelled IHME
3.92 (3.15 - 4.93) 1993 Modelled IHME
4.01 (3.21 - 5.07) 1992 Modelled IHME
4.09 (3.29 - 5.15) 1991 Modelled IHME
4.16 (3.34 - 5.24) 1990 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.94 (1.81 - 4.60) 2019 Modelled IHME
2.94 (1.84 - 4.68) 2018 Modelled IHME
2.9 (1.83 - 4.53) 2017 Modelled IHME
2.85 (1.79 - 4.50) 2016 Modelled IHME
2.8 (1.77 - 4.40) 2015 Modelled IHME
2.81 (1.77 - 4.39) 2014 Modelled IHME
2.85 (1.81 - 4.43) 2013 Modelled IHME
2.91 (1.82 - 4.51) 2012 Modelled IHME
2.94 (1.83 - 4.61) 2011 Modelled IHME
2.9 (1.79 - 4.53) 2010 Modelled IHME
2.96 (1.82 - 4.55) 2009 Modelled IHME
3.01 (1.85 - 4.56) 2008 Modelled IHME
3.13 (1.96 - 4.72) 2007 Modelled IHME
3.25 (2.03 - 4.89) 2006 Modelled IHME
3.33 (2.13 - 5.01) 2005 Modelled IHME
3.44 (2.22 - 5.09) 2004 Modelled IHME
3.55 (2.30 - 5.21) 2003 Modelled IHME
3.72 (2.42 - 5.44) 2002 Modelled IHME
4.03 (2.62 - 5.83) 2001 Modelled IHME
4.33 (2.85 - 6.20) 2000 Modelled IHME
4.58 (3.03 - 6.57) 1999 Modelled IHME
4.79 (3.20 - 6.81) 1998 Modelled IHME
5.07 (3.35 - 7.34) 1997 Modelled IHME
5.48 (3.59 - 8.12) 1996 Modelled IHME
5.67 (3.65 - 8.38) 1995 Modelled IHME
5.85 (3.75 - 8.60) 1994 Modelled IHME
6.12 (3.92 - 9.05) 1993 Modelled IHME
6.37 (4.04 - 9.42) 1992 Modelled IHME
6.68 (4.26 - 9.80) 1991 Modelled IHME
6.93 (4.37 - 10.30) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
42 (26 - 65) 2019 Modelled IHME
40 (25 - 65) 2018 Modelled IHME
39 (24 - 61) 2017 Modelled IHME
37 (23 - 58) 2016 Modelled IHME
35 (22 - 55) 2015 Modelled IHME
34 (21 - 53) 2014 Modelled IHME
33 (21 - 52) 2013 Modelled IHME
33 (20 - 51) 2012 Modelled IHME
32 (20 - 50) 2011 Modelled IHME
30 (19 - 47) 2010 Modelled IHME
30 (18 - 46) 2009 Modelled IHME
29 (18 - 44) 2008 Modelled IHME
29 (18 - 43) 2007 Modelled IHME
29 (18 - 43) 2006 Modelled IHME
28 (18 - 42) 2005 Modelled IHME
28 (18 - 41) 2004 Modelled IHME
27 (18 - 40) 2003 Modelled IHME
27 (18 - 40) 2002 Modelled IHME
28 (18 - 41) 2001 Modelled IHME
29 (19 - 41) 2000 Modelled IHME
29 (19 - 42) 1999 Modelled IHME
29 (19 - 41) 1998 Modelled IHME
29 (19 - 43) 1997 Modelled IHME
30 (20 - 45) 1996 Modelled IHME
30 (19 - 45) 1995 Modelled IHME
30 (19 - 44) 1994 Modelled IHME
30 (19 - 44) 1993 Modelled IHME
30 (19 - 44) 1992 Modelled IHME
30 (19 - 44) 1991 Modelled IHME
30 (19 - 44) 1990 Modelled IHME
97 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
39 (30 - 48) 2019 Modelled IHME
39 (30 - 48) 2018 Modelled IHME
39 (30 - 48) 2017 Modelled IHME
38 (30 - 48) 2016 Modelled IHME
39 (30 - 48) 2015 Modelled IHME
39 (30 - 47) 2014 Modelled IHME
39 (30 - 47) 2013 Modelled IHME
38 (30 - 47) 2012 Modelled IHME
38 (29 - 47) 2011 Modelled IHME
38 (29 - 47) 2010 Modelled IHME
38 (29 - 47) 2009 Modelled IHME
38 (29 - 47) 2008 Modelled IHME
38 (29 - 47) 2007 Modelled IHME
38 (29 - 47) 2006 Modelled IHME
38 (29 - 47) 2005 Modelled IHME
39 (30 - 47) 2004 Modelled IHME
39 (30 - 48) 2003 Modelled IHME
39 (30 - 48) 2002 Modelled IHME
39 (31 - 48) 2001 Modelled IHME
39 (31 - 48) 2000 Modelled IHME
40 (31 - 48) 1999 Modelled IHME
40 (31 - 48) 1998 Modelled IHME
40 (31 - 49) 1997 Modelled IHME
41 (31 - 49) 1996 Modelled IHME
41 (32 - 49) 1995 Modelled IHME
41 (32 - 50) 1994 Modelled IHME
41 (32 - 50) 1993 Modelled IHME
41 (32 - 50) 1992 Modelled IHME
41 (33 - 50) 1991 Modelled IHME
42 (33 - 50) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2018
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
1.26 (%)
2019
(1.09 - 1.43(%))
IHME
HCV (RNA/cAg+)
2.27 (%)
2019
(1.82 - 2.87(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
47
2019
(28 - 74)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
42
2019
(26 - 65)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.48 (%)
2019, latest modelled
(0.36 - 0.62(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources